CanSino Biologics Inc (CJH) — Cash Flow Quality Index
CanSino Biologics Inc (CJH) has a Cash Flow Quality Index of -4.93x as of March 2022. Operating cash flow of €-598.15 Million is below net income of €121.41 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore CanSino Biologics Inc cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
CanSino Biologics Inc Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for CanSino Biologics Inc across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see CJH cash flow metrics.
Annual Cash Flow Quality Index for CanSino Biologics Inc (2021–2025)
Year-by-year earnings quality comparison for CanSino Biologics Inc.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.79x | €77.86 Million | €27.87 Million | ▲ +160.8% |
| 2021 | 1.07x | €2.05 Billion | €1.91 Billion | — |